BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33306189)

  • 21. Circulating microRNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: a meta-analysis based on 42 articles.
    Wang R; Wen H; Xu Y; Chen Q; Luo Y; Lin Y; Luo Y; Xu A
    PLoS One; 2014; 9(11):e113401. PubMed ID: 25406082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and Endoscopic Characteristics Associated With Post-Endoscopy Upper Gastrointestinal Cancers: A Systematic Review and Meta-analysis.
    Alexandre L; Tsilegeridis-Legeris T; Lam S
    Gastroenterology; 2022 Apr; 162(4):1123-1135. PubMed ID: 34958760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers.
    Albulescu R; Neagu M; Albulescu L; Tanase C
    Expert Rev Mol Diagn; 2011 Jan; 11(1):101-20. PubMed ID: 21171925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress with Metabolomic Blood Tests for Gastrointestinal Cancer Diagnosis-An Assessment of Biomarker Translation.
    Savva KV; Das B; Antonowicz S; Hanna GB; Peters CJ
    Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2095-2105. PubMed ID: 36215181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum IGFBP-1 as a potential biomarker for diagnosis of early-stage upper gastrointestinal tumour.
    Xu YW; Chen H; Hong CQ; Chu LY; Yang SH; Huang LS; Guo H; Chen LY; Liu CT; Huang XY; Lin LH; Chen SL; Wu ZY; Peng YH; Xu LY; Li EM
    EBioMedicine; 2020 Jan; 51():102566. PubMed ID: 31901863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing early upper gastrointestinal cancer detection at endoscopy.
    Veitch AM; Uedo N; Yao K; East JE
    Nat Rev Gastroenterol Hepatol; 2015 Nov; 12(11):660-7. PubMed ID: 26260369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018.
    Vangala DB; Cauchin E; Balmaña J; Wyrwicz L; van Cutsem E; Güller U; Castells A; Carneiro F; Hammel P; Ducreux M; van Laethem JL; Matysiak-Budnik T; Schmiegel W
    Eur J Cancer; 2018 Nov; 104():91-103. PubMed ID: 30342310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis.
    Yamada A; Komaki Y; Komaki F; Micic D; Zullow S; Sakuraba A
    Lancet Oncol; 2018 Jun; 19(6):758-767. PubMed ID: 29706374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarker discovery and validation for gastrointestinal tumors: A comprehensive review of colorectal, gastric, and liver cancers.
    Hakami ZH
    Pathol Res Pract; 2024 Mar; 255():155216. PubMed ID: 38401376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis.
    Creemers A; Krausz S; Strijker M; van der Wel MJ; Soer EC; Reinten RJ; Besselink MG; Wilmink JW; van de Vijver MJ; van Noesel CJM; Verheij J; Meijer SL; Dijk F; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):394-403. PubMed ID: 28801248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers for personalized medicine in GI cancers.
    Zhang SY; Zhang SQ; Nagaraju GP; El-Rayes BF
    Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
    Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
    PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends of primary and subsequent cancers of the gastrointestinal tract in the Czech population, 1976-2005.
    Dítě P; Geryk E
    Dig Dis; 2010; 28(4-5):657-69. PubMed ID: 21088418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolomics profile in gastrointestinal cancers: Update and future perspectives.
    Nannini G; Meoni G; Amedei A; Tenori L
    World J Gastroenterol; 2020 May; 26(20):2514-2532. PubMed ID: 32523308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood Biomarkers of Glioma in Response Assessment Including Pseudoprogression and Other Treatment Effects: A Systematic Review.
    Raza IJ; Tingate CA; Gkolia P; Romero L; Tee JW; Hunn MK
    Front Oncol; 2020; 10():1191. PubMed ID: 32923382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNAs as diagnostic biomarkers for the early detection of digestive tract cancers: a systematic review and meta-analysis.
    Yu Y; Zhao Y; Wang C; Zhang X; Liu X
    Rev Esp Enferm Dig; 2020 Oct; 112(10):797-804. PubMed ID: 32338027
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.